Alternatives to Elea & Lili

Empowering Venture Scientists to solve neglected health and planetary challenges through an entrepreneurship-focused doctoral training program.

Cultivating wood directly into its final shape, 10,000x faster than forestry.

Turning CO2 into cellulose for textiles using an innovative, carbon-negative enzymatic process.

Developing high-performance, compostable foams from bacterial cellulose to replace fossil-based plastics.

Epoch Biodesign uses enzymes to break down plastic waste into monomers for new plastic production.

Pioneering Liquid State Intelligence for physical-world AI.

UK biotechnology company developing sustainable natural rubber from engineered dandelions.

Developing a sustainable plastic alternative called Vivomer.

Developing cellulose-based alternatives to titanium dioxide for cosmetics, food, and coatings.

Developing next-generation nanozyme catalysts to enable a more sustainable and efficient chemical production industry.

A University of Cambridge spin-out tackling unmet drug screening needs by combining materials engineering and cell biology.

Developing a new generation of molecular diagnostics for at-home use, combining laboratory accuracy with rapid test simplicity.

Developing disease-resistant crops using AI-driven platform to resurrect native resistance mechanisms.

A leading incubator and venture builder in deep tech and life science.

Developing circular biomass technology.

Developing biobased alternatives to conventional carbon-intensive construction binders.

Using microorganisms as programmable molecular factories for industrial ingredients.

Notpla develops and produces sustainable, plastic-free packaging solutions from seaweed and plants, offering biodegradable and compostable alternatives for various applications.

Revolutionizing battery recycling for a circular future in Europe.

Industrial biotechnology company developing optogenetic control for industrial-scale precision fermentation.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

CleanTech company specializing in PET/polyester plastics and fibres recycling using microwave-assisted depolymerisation.

Developing proprietary nano-ink technology for inkjet printing of printed circuit boards (PCBs).

Biotech startup using organelle engineering to develop novel, high-value traits for agricultural crops.

AI safety and research company building reliable, interpretable, and steerable AI systems.

Building foundational AI superintelligence to accelerate scientific knowledge discovery and breakthroughs across complex domains.

Danish biofuel startup developing a patented process to convert lignin-based residues into climate-neutral marine fuels.

Biotechnology company developing and commercializing cell therapies for cancer treatment.

Global biopharmaceutical company pioneering mRNA-based immunotherapies and vaccines for cancer and infectious diseases.

Next-generation metals processing infrastructure for critical and precious metals recovery.

Biotechnology company developing transformative gene-based medicines using CRISPR/Cas9 gene editing technology.

Biotechnology company leveraging ultracompact CRISPR systems for gene editing therapies and diagnostics.

Clinical-stage biotechnology company developing autologous neuron replacement medicines for neurodegenerative disorders.

Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.

Developing novel therapeutics to restore gut lymphatic function.

Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).

Global supplier of life science research tools, including antibodies, reagents, and assays.

Spatial multiomics company developing technologies for single-cell gene expression profiling in intact tissues.

Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.

Clinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.

Developing first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.

Biopharmaceutical company developing and commercializing CNS disease treatments.

A clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.

Enzyme-based technology to break down alcohol in the stomach.

A vertically-integrated procurement platform for the life sciences industry.

Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.

A leading organization dedicated to curing and treating cystic fibrosis.

Freenome is a biotechnology company developing a multi-cancer early detection blood test using machine learning and biology.

A global leader in clinical pharmacology and bioanalytical sciences.

Deeptech startup developing advanced materials for industrial separation and water treatment.

Biopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).

Personalizing cancer care through a novel, physics-informed approach to predict tumor response to therapy.

A biotechnology company developing gene therapy treatments for rare, debilitating genetic diseases.